Information Collection Request

Population Assessment of Tobacco and Health (PATH) Study - Fourth Wave of Data Collection (NIDA)

ICR 201606-0925-008 · OMB 0925-0664 · Historical Active

Forms and Documents
DocumentTypeStatusAvailability
Form 1 Path Study Data Collection Instruments Form and Instruction New Available
Form 1-Rev Instruments for Wave 3 of the PATH Study Form and Instruction Removed Repair queued
Attach2a PATH Study Data Collection Instruments.pdf Supplementary Document Uploaded 2016-11-04 Available
Attach2b PATH Study Data Collection Instruments.pdf Supplementary Document Uploaded 2016-11-04 Available
Attach4 Summary of Changes to Instruments for Wave 4.pdf Supplementary Document Uploaded 2016-11-04 Available
PATH 30-day.pdf Supplementary Document Uploaded 2016-07-01 Repair queued
Revised_ PATH Study W4 SSA 100716.docx Supporting Statement A Uploaded 2016-11-04 Available
Attach21. Statistical Consultants.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach20. PATH Study Interim Report.pdf Supplementary Document Uploaded 2016-06-27 Repair queued
Attach19. Sample Analysis Plans.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach17. ICPSR Data Use Agreement.pdf Supplementary Document Uploaded 2016-06-27 Repair queued
Attach16. Procedures for Keeping Data Confidential.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach15. Privacy Act System of Records Notice.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach14. IRB Approval Memo.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach13. Assurance of Confidentiality.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach12. NIH Confidentiality Certificate.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach10. List of Consultants .pdf Supplementary Document Uploaded 2016-06-27 Available
Attach8. Key Design Features.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach7. PATH Study Privacy Impact Assessments (PIA).pdf Supplementary Document Uploaded 2016-06-27 Available
Attach5. Sample Conceptual Models.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach3. Crosswalk of PATH Study Objectives, Data Sources, Domains, and Analysis.pdf Supplementary Document Uploaded 2016-06-27 Available
Attach1. NIDA's Data Collection Authority.pdf Supplementary Document Uploaded 2016-06-27 Available
PATH W4 SSB final 062416.docx Supporting Statement B Uploaded 2016-06-27 Available
IC Document Collections
IC IDCollectionTypeStatusForm
222213 Path Study Data Collection Instruments Form and Instruction New
212557 Instruments for Wave 3 of the PATH Study Form and Instruction Removed
ICR Details
0925-0664 201606-0925-008
Historical Active 201510-0925-001
HHS/NIH 21181
Population Assessment of Tobacco and Health (PATH) Study - Fourth Wave of Data Collection (NIDA)
Revision of a currently approved collection   No
Regular
Approved with change 11/08/2016
Retrieve Notice of Action (NOA) 07/05/2016
OMB approval is provided for sample replenishment as well as data collection for Wave 4 of the PATH Study. A separate three-year clearance request will be submitted for subsequent waves, which may focus on selected subsamples. The revision will describe the response rate and characteristics of the sample replenishment. NIDA, FDA, and the PATH Study team will work together with OMB to ensure there is no duplication in the type of information generated by the PATH Study and other information collections, such as the recently-approved collection requests for FDA’s CTP.
  Inventory as of this Action Requested Previously Approved
05/31/2018 36 Months From Approved 08/31/2018
442,123 0 192,858
94,798 0 54,434
0 0 0

This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct the fourth wave of data collection. The PATH Study is collecting behavioral data and biospecimens among a national longitudinal cohort to assess within-person changes and between-person differences in tobacco-product use behaviors and related health conditions over time. Its longitudinal, population-based data will help to enhance the evidence base that informs FDA’s regulatory actions under the Family Smoking Prevention and Tobacco Control Act (TCA) to protect the Nation’s public health and reduce its burden of tobacco-related morbidity and mortality.

US Code: 42 USC 285o Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  81 FR 22290 04/15/2016
81 FR 43217 07/01/2016
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 442,123 192,858 0 249,265 0 0
Annual Time Burden (Hours) 94,798 54,434 0 40,364 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
Yes
Miscellaneous Actions
This is a revision request (OMB number 0925-0664, expiration date 8/31/2018) for the Population Assessment of Tobacco and Health (PATH) Study to conduct Wave 4 of data collection. An increase of 40,364 burden hours is estimated between Wave 3 (54,434) and Wave 4 (94,798). The factors accounting for this increase include the addition of: (1) household and shadow youth only screenings, (2) data collection for new adult and new youth participants, (3) urine and blood collection for new adults, and (4) urine collection for all youth.

$94,455,105
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Tawanda Abdelmouti 240 276-5530 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/05/2016